Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,816.89
(
-0.11%
)
US TECH 100
24,499.60
(
0.38%
)
Dow Jones
47,916.57
(
-0.56%
)
Brent Oil
98.65
(
-1.21%
)
Bitcoin
70,998.91
(
0.32%
)
News Focus
News Focus
Post# of 821157
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

biosectinvestor

Send PM Follow Ignore
Followers 200
Posts 25596
Boards Moderated 0
Alias Born 04/03/2010

biosectinvestor

Re: Umibe5690 post# 521169

Wednesday, 10/12/2022 5:12:04 PM

Wednesday, October 12, 2022 5:12:04 PM

Post# of 821157
I have said I from the start that if no US journal would be willing to accept some sort of language relating to the outstanding ECA guidance, and I do think that side article was an effort by FDA to maybe be broadly more affirmative of the policy than the rest of the agency, that then they would most likely go with a UK journal. I believe BMJ or The Lancet or Nature would be the most likely preferred candidates.

I own NWBO. My posts on iHub are always posted expressly as just my humble opinion (IMHO) and none are advice, just my opinion. I am NOT a financial advisor, and it is assumed that everyone is responsible for their own due diligence.

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent NWBO News
More NWBO News